News Focus
News Focus
icon url

seekinganswers

09/11/25 7:24 AM

#787638 RE: Guzzi62 #787637

What does that mean to you?
icon url

Zadie420

09/11/25 9:03 AM

#787646 RE: Guzzi62 #787637

I guess the UK government balk at cost of using K treatment which is north of $400K, not including side effects. This will open the room for DCVax-L /Poly-ICLC treatment which is much cheaper.
icon url

ilovetech

09/11/25 9:47 AM

#787655 RE: Guzzi62 #787637

I'm not surprised. The financial crisis has accelerated over the last three years, while Gov't assurances have come up empty apparently one too many times.
icon url

Investor082

09/11/25 2:26 PM

#787720 RE: Guzzi62 #787637

Also, another warning and indicator to all the folks living in denial here about Merck. Merck is simply not interested in NWBO and are not having any discussions with NWBO.

They just don’t see UK as a big revenue generating market for them (which is where NWBO is putting all their bets on). Low drug prices, huge clawback rates, and a lack of investment from UK government are some of the reasons big pharmas are cutting their exposure to the UK.